Why the study?
Myocarditis poses significant clinical challenges, and this study aimed to explore the expanding role of artificial intelligence in myocarditis to consolidate current knowledge and guide future research.
What is the role and performance of artificial intelligence in the diagnosis, survival prediction, and molecular analysis of myocarditis?
What is the role and performance of artificial intelligence in the diagnosis, survival prediction, and molecular analysis of myocarditis?
This systematic review highlights the transformative potential of artificial intelligence in enhancing the diagnosis, risk stratification, and molecular understanding of myocarditis.
Answers are grounded in this paper and cite their sources.
Supports AI-assisted myocarditis diagnosis and risk stratification; extends modeling data toward prospective validation.
Myocarditis, marked by heart muscle inflammation, poses significant clinical challenges. This study, guided by PRISMA guidelines, explores the expanding role of artificial intelligence (AI) in myocarditis, aiming to consolidate current knowledge and guide future research. Following PRISMA guidelines, a systematic review was conducted across PubMed, Cochrane Reviews, Scopus, Embase, and Web of Science databases. MeSH terms including artificial intelligence, deep learning, machine learning, myocarditis, and inflammatory cardiomyopathy were used. Inclusion criteria involved original articles utilizing AI for myocarditis, while exclusion criteria eliminated reviews, editorials, and non-AI-focused studies. The search yielded 616 articles, with 42 meeting inclusion criteria after screening. The identified articles, spanning diagnostic, survival prediction, and molecular analysis aspects, were analyzed in each subsection. Diagnostic studies showcased the versatility of AI algorithms, achieving high accuracies in myocarditis detection. Survival prediction models exhibited robust discriminatory power, particularly in emergency settings and pediatric populations. Molecular analyses demonstrated AI's potential in deciphering complex immune interactions. This systematic review provides a comprehensive overview of AI applications in myocarditis, highlighting transformative potential in diagnostics, survival prediction, and molecular understanding. Collaborative efforts are crucial for overcoming limitations and realizing AI's full potential in improving myocarditis care.
No takes yet. Share an insight, caveat, or question.
Łajczak et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: